{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:30:56Z","timestamp":1776922256367,"version":"3.51.2"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1124\/jpet.123.001920","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T18:25:28Z","timestamp":1703183128000},"page":"688-700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The \u03b2-Blocker Carvedilol and Related Aryloxypropanolamines Promote ERK1\/2 Phosphorylation in HEK293 Cells with KA Values Distinct From Their Equilibrium Dissociation Constants as \u03b22-Adrenoceptor Antagonists: Evidence for Functional Affinity"],"prefix":"10.1016","volume":"388","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9893-704X","authenticated-orcid":false,"given":"Omar","family":"Hamed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varuna","family":"Jayasinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Giembycz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.123.001920_bib1","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1016\/j.bmcl.2004.06.086","article-title":"Long-chain formoterol analogues: an investigation into the effect of increasing amino-substituent chain length on the \u03b22-adrenoceptor activity","volume":"14","author":"Alikhani","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/jpet.123.001920_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.bjp.0706048","article-title":"The selectivity of \u03b2-adrenoceptor antagonists at the human \u03b21, \u03b22 and \u03b23 adrenoceptors","volume":"144","author":"Baker","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.123.001920_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tips.2011.02.010","article-title":"Evolution of \u03b2-blockers: from anti-anginal drugs to ligand-directed signalling","volume":"32","author":"Baker","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.123.001920_bib4","first-page":"1022","article-title":"Cardiac action of carazolol and methypranol in comparison with other beta-receptor blockers","volume":"27","author":"Bartsch","year":"1977","journal-title":"Arzneimittelforschung"},{"key":"10.1124\/jpet.123.001920_bib5","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1038\/s41467-022-34765-w","article-title":"How carvedilol activates \u03b22-adrenoceptors","volume":"13","author":"Benkel","year":"2022","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.123.001920_bib6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1476-5381.1985.tb12941.x","article-title":"An operational model of pharmacological agonism: the effect of E\/[A] curve shape on agonist dissociation constant estimation","volume":"84","author":"Black","year":"1985","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.123.001920_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJM198207223070401","article-title":"Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts","volume":"307","author":"Bristow","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.123.001920_bib8","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/sj.bjp.0704188","article-title":"Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium","volume":"133","author":"Brixius","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.123.001920_bib8a","doi-asserted-by":"crossref","first-page":"E4107","DOI":"10.1073\/pnas.1606267113","article-title":"\u03b2-arrestin-biased signaling through the \u03b22-adrenergic receptor promotes cardiomyocyte contraction.","volume":"113","author":"Carr","year":"2016","journal-title":"Proc Natl Acad Sc USA"},{"key":"10.1124\/jpet.123.001920_bib9","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.2042-7158.1983.tb04339.x","article-title":"A comparison of the selectivity of carazolol with that of other \u03b2 2-selective adrenoceptor antagonists","volume":"35","author":"Costin","year":"1983","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/jpet.123.001920_bib10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature18324","article-title":"Allosteric coupling from G protein to the agonist-binding pocket in GPCRs","volume":"535","author":"DeVree","year":"2016","journal-title":"Nature"},{"key":"10.1124\/jpet.123.001920_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.bjp.0701801","article-title":"Irreversible binding of a carbostyril-based agonist and antagonist to the beta-adrenoceptor in DDT1 MF-2 cells and rat aorta","volume":"124","author":"Deyrup","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.123.001920_bib12","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1124\/mol.106.026716","article-title":"Distinct signaling profiles of \u03b21 and \u03b22 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy","volume":"70","author":"Galandrin","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.123.001920_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2165\/00003495-197407010-00002","article-title":"Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man","volume":"7","author":"Gibson","year":"1974","journal-title":"Drugs"},{"key":"10.1124\/jpet.123.001920_bib14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1124\/jpet.113.206284","article-title":"Concurrent agonism of adenosine A2B and glucocorticoid receptors in human airway epithelial cells cooperatively induces genes with anti-inflammatory potential: a novel approach to treat chronic obstructive pulmonary disease","volume":"346","author":"Greer","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001920_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41467-017-02661-3","article-title":"Lack of beta-arrestin signaling in the absence of active G proteins","volume":"9","author":"Grundmann","year":"2018","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.123.001920_bib16","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1111\/bph.15269","article-title":"Metabolic effects of carvedilol through \u03b2-arrestin proteins: investigations in a streptozotocin-induced diabetes rat model and in C2C12 myoblasts","volume":"177","author":"G\u00fcven","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.123.001920_bib17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1124\/molpharm.121.000294","article-title":"\u03b22-Adrenoceptor agonists promote extracellular signal-regulated kinase 1\/2 dephosphorylation in human airway epithelial cells by canonical, cAMP-driven signaling independently of \u03b2-arrestin 2","volume":"100","author":"Hamed","year":"2021","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.123.001920_bib18","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1111\/bph.15901","article-title":"\u03b1 and \u03b2 catalytic subunits of cAMP-dependent protein kinase regulate formoterol-induced inflammatory gene expression changes in human bronchial epithelial cells","volume":"179","author":"Hamed","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.123.001920_bib19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3565(25)23687-4","article-title":"Coexistence of beta-1 and beta-2 adrenergic receptors in the human heart: effects of treatment with receptor antagonists or calcium entry blockers","volume":"234","author":"Hedberg","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001920_bib20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0026-895X(25)09939-0","article-title":"Amplification of cyclic AMP generation reveals agonistic effects of certain beta-adrenergic antagonists","volume":"37","author":"Jasper","year":"1990","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.123.001920_bib21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nchembio.634","article-title":"Multiple ligand-specific conformations of the \u03b22-adrenergic receptor","volume":"7","author":"Kahsai","year":"2011","journal-title":"Nat Chem Biol"},{"key":"10.1124\/jpet.123.001920_bib22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tips.2014.06.003","article-title":"What is pharmacological \u201caffinity\u201d? Relevance to biased agonism and antagonism","volume":"35","author":"Kenakin","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.123.001920_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/bcp.12810","article-title":"The mass action equation in pharmacology","volume":"81","author":"Kenakin","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.123.001920_bib24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1124\/pr.118.016790","article-title":"Biased receptor signaling in drug discovery","volume":"71","author":"Kenakin","year":"2019","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.123.001920_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd3954","article-title":"Signalling bias in new drug discovery: detection, quantification and therapeutic impact","volume":"12","author":"Kenakin","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.123.001920_bib26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41586-022-05343-3","article-title":"Non-canonical \u03b2-adrenergic activation of ERK at endosomes","volume":"611","author":"Kwon","year":"2022","journal-title":"Nature"},{"key":"10.1124\/jpet.123.001920_bib27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.bjp.0707372","article-title":"Good statistical practice in pharmacology. Problem 2","volume":"152","author":"Lew","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.123.001920_bib28","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1126\/science.1215802","article-title":"Biased signaling pathways in \u03b22-adrenergic receptor characterized by 19F-NMR","volume":"335","author":"Liu","year":"2012","journal-title":"Science"},{"key":"10.1124\/jpet.123.001920_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aat7650","article-title":"Manifold roles of \u03b2-arrestins in GPCR signaling elucidated with siRNA and CRISPR\/Cas9","volume":"11","author":"Luttrell","year":"2018","journal-title":"Sci Signal"},{"key":"10.1124\/jpet.123.001920_bib30","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.recesp.2019.02.024","article-title":"Role of beta-blockers in cardiovascular disease in 2019","volume":"72","author":"Mart\u00ednez-Milla","year":"2019","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1124\/jpet.123.001920_bib31","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1124\/jpet.123.001920_bib32","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1124\/jpet.103.060020","article-title":"Adenovirus-mediated delivery and expression of a cAMP-dependent protein kinase inhibitor gene to BEAS-2B epithelial cells abolishes the anti-inflammatory effects of rolipram, salbutamol, and prostaglandin E2: a comparison with H-89","volume":"309","author":"Meja","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001920_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173632","article-title":"\u03b11-adrenoceptor activity of \u03b2-adrenoceptor ligands\u2014an expected drug property with limited clinical relevance","volume":"889","author":"Michel","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.123.001920_bib34","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1440-1681.2007.04730.x","article-title":"Human heart \u03b2-adrenoceptors: \u03b21-adrenoceptor diversification through \u201caffinity states\u201d and polymorphism","volume":"34","author":"Molenaar","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1124\/jpet.123.001920_bib35","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1021\/acs.jmedchem.6b01857","article-title":"Discovery of G protein-biased dopaminergics with a pyrazolo[1,5-a]pyridine substructure","volume":"60","author":"M\u00f6ller","year":"2017","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.123.001920_bib36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/chir.530010404","article-title":"The interaction of the enantiomers of carvedilol with \u03b1 1- and \u03b2 1-adrenoceptors","volume":"1","author":"Nichols","year":"1989","journal-title":"Chirality"},{"key":"10.1124\/jpet.123.001920_bib37","doi-asserted-by":"crossref","first-page":"17201","DOI":"10.1074\/jbc.M910348199","article-title":"Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors","volume":"275","author":"Oakley","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.123.001920_bib38","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jacbts.2018.06.002","article-title":"Carvedilol prevents redox inactivation of cardiomyocyte \u03b21-adrenergic receptors","volume":"3","author":"Park","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"10.1124\/jpet.123.001920_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"key":"10.1124\/jpet.123.001920_bib40","article-title":"The affinity and selectivity of \u03b1-adrenoceptor antagonists, antidepressants and antipsychotics for the human \u03b12A, \u03b12B, and \u03b12C-adrenoceptors and comparison with human \u03b11 and \u03b2-adrenoceptors","volume":"10","author":"Proudman","year":"2022","journal-title":"Pharmacol Res Perspect"},{"key":"10.1124\/jpet.123.001920_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.602","article-title":"The affinity and selectivity of \u03b1-adrenoceptor antagonists, antidepressants, and antipsychotics for the human \u03b11A, \u03b11B, and \u03b11D-adrenoceptors","volume":"8","author":"Proudman","year":"2020","journal-title":"Pharmacol Res Perspect"},{"key":"10.1124\/jpet.123.001920_bib42","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.49464","article-title":"\u03b2-blockers augment L-type Ca2+ channel activity by targeting spatially restricted \u03b22AR signaling in neurons","volume":"8","author":"Shen","year":"2019","journal-title":"eLife"},{"key":"10.1124\/jpet.123.001920_bib43","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature18636","article-title":"Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation","volume":"535","author":"Staus","year":"2016","journal-title":"Nature"},{"key":"10.1124\/jpet.123.001920_bib44","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0006-291X(84)90729-0","article-title":"Comparison of rat and human left ventricle beta-adrenergic receptors: subtype heterogeneity delineated by direct radioligand binding","volume":"121","author":"Vago","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.123.001920_bib45","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1124\/mol.113.088880","article-title":"Quantification of ligand bias for clinically relevant \u03b22-adrenergic receptor ligands: implications for drug taxonomy","volume":"85","author":"van der Westhuizen","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.123.001920_bib46","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s41467-017-01855-z","article-title":"G\u03b1i is required for carvedilol-induced \u03b21 adrenergic receptor \u03b2-arrestin biased signaling","volume":"8","author":"Wang","year":"2017","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.123.001920_bib47","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/molpharm.121.000359","article-title":"\u03b2-Arrestin-biased allosteric modulator potentiates carvedilol-stimulated \u03b2-adrenergic receptor cardioprotection","volume":"100","author":"Wang","year":"2021","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.123.001920_bib48","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/0024-3205(78)90096-6","article-title":"Kinetic and empirical analysis of dose-response curves illustrated with a cardiac example","volume":"22","author":"Waud","year":"1978","journal-title":"Life Sci"},{"key":"10.1124\/jpet.123.001920_bib49","doi-asserted-by":"crossref","first-page":"16657","DOI":"10.1073\/pnas.0707936104","article-title":"A unique mechanism of \u03b2-blocker action: carvedilol stimulates \u03b2-arrestin signaling","volume":"104","author":"Wisler","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.123.001920_bib50","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1111\/bph.13049","article-title":"Advances in receptor conformation research: the quest for functionally selective conformations focusing on the \u03b22-adrenoceptor","volume":"172","author":"Woo","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.123.001920_bib51","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/jpet.118.249292","article-title":"Analysis of the indacaterol-regulated transcriptome in human airway epithelial cells implicates gene expression changes in the adverse and therapeutic effects of \u03b22-adrenoceptor agonists","volume":"366","author":"Yan","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001920_bib52","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3390\/molecules26020468","article-title":"Progress in the enantioseparation of \u03b2-blockers by chromatographic methods","volume":"26","author":"Yang","year":"2021","journal-title":"Molecules"},{"key":"10.1124\/jpet.123.001920_bib53","doi-asserted-by":"crossref","first-page":"621","DOI":"10.13005\/bpj\/1414","article-title":"The scattered twelve tribes of HEK293","volume":"11","author":"Yuan","year":"2018","journal-title":"Biomed Pharmacol J"}],"updated-by":[{"DOI":"10.1124\/jpet.123.001920err","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000}}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524171984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524171984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.123.001920","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T22:25:19Z","timestamp":1743200719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524171984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0022356524171984"],"URL":"https:\/\/doi.org\/10.1124\/jpet.123.001920","relation":{"erratum":[{"id-type":"doi","id":"10.1124\/jpet.123.001920err","asserted-by":"object"}]},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The \u03b2-Blocker Carvedilol and Related Aryloxypropanolamines Promote ERK1\/2 Phosphorylation in HEK293 Cells with KA Values Distinct From Their Equilibrium Dissociation Constants as \u03b22-Adrenoceptor Antagonists: Evidence for Functional Affinity","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.123.001920","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}